Earnings call Veracyte delivered a milestone Q2 2026 with total revenue of $150.3M, up 15% YoY, and adjusted EBITDA of $44M (29.2% margin). Management raised full-year revenue guidance to $590–$596M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results